Sunday, March 6, 2016

#8 - Analysis of CQ Researcher Pro/Con discussion

Pro/Con Question: Should CDC funding be raised to fight emerging diseases?

The thesis of the Pro side: CDC funding should be raised to fight emerging diseases.

This side is defended by Stephen Calderwood MD, president of the Infectious Diseases Society of America.

His argument:

1. Widespread outbreaks, such as H1N1 pandemic influenza, have emerged in the past few years, but they also pose a threat for the future, for instance the ongoing Ebola outbreak. These infectious agents take a large toll on patients and their families. We cannot be unprepared for these infectious threats, both emerging and re-emerging.
 
2. There are threats that have been with us for decades, for example antibiotic-resistant bacteria, U.S. health's "ticking time bombs". Many people are undiagnosed or lack treatment for HIV/AIDS, tuberculosis, and hepatitis C, which are putting a strain on our health care system. If we do not make a greater effort to prevent and treat these diseases, the problem may become so large that we no longer have the ability to respond.
 
3. Instead of relying on emergency funding when a new infectious disease threat emerges, a more stable system with long-term planning must be produced so that we can better detect and respond to these threats.
 
4. The CDC provides infectious disease surveillance and coordinates preparedness and response efforts. Therefore, we count on the CDC to respond when a threat emerges. Despite this, the agency's funding was cut nearly $600 million. The best way to secure Americans against microbial threats is through a public-health infrastructure that is sustainable and has stable financing.
 
Analysis:
 
Outbreaks have posed a serious threat over the past few years, and it is imperative that the United States has a dependable agency to prepare for potential threats, be able to detect them, and have response efforts immediately ready when we need them. Calderwood's argument supports raising CDC funding to fight emerging diseases, and he makes a strong case. Calderwood states how the CDC is the primary resource for detecting and handling serious outbreaks. Therefore, the agency needs to have the proper funding to be able to provide these services and keep Americans safe from these threats. He illustrates how there are both emerging and re-emerging threats, as well as threats that have strained our health care system for decades. Without these resources, many families will be greatly affected, and the problem may become so large that a response will not be able to solve the problem. Hence, a stable system with long-term planning must be available, and raising CDC funding will help achieve such a system.
 

Wednesday, March 2, 2016

#7 - Evaluation of authority and currency of book in post #3

Book: Emerging epidemics: management and control, by Prakash S. Bisen, 2013.


 
Prakash S. Bisen is a professor, and he earned his PhD in 1972. He worked at two different universities in India teaching Microbiology. He was also a visiting professor at the University of Lancaster in England and a visiting research professor in the department of biological sciences at the University of Illinois at Chicago. He worked in the department of bacteriology at the University of California at Davis as a U.S. National Science Foundation Fellow. Professor Bisen was also a fellow for a year at universities in Czechoslovakia and Hungary. He is currently performing research in medical biotechnology as an Emeritus Scientist at the Defense Research Development Establishment in India. He is the external advisor for the company Biokit, which is based in Barcelona, Spain, and is the head of research and development for Tropilite Foods, which involves food biotechnology and creates products for the food industry.

Professor Bisen guided sixty doctoral theses and published 175 research papers from 1974-2012. Over the years, he has lead the world in rapid tuberculosis diagnostics. The technology developed in his group has been patented in India, the U.S., Europe, and Japan. In addition to the six patents already published, others are currently under review. He also invented what is known as Eastern Blotting. Furthermore, he has published eight books internationally.
 
Prakash Bisen is highly qualified to write a book on the topic of emerging epidemics. His extensive and diverse experiences as a researcher, along with his major contributions to the field through his research papers, patents, and books, make him well qualified.
 
This book was published in 2013. Although the book is only three years old, new developments are constantly made on the topic of emerging infectious diseases. Therefore, it would be good to supplement this book with books and scholarly articles published at a more recent date when completing a research project on newly discovered infectious diseases.